Synergistic interactions between paracetamol and oxcarbazepine in somatic and visceral pain models in rodents

Anesthesia and Analgesia

Volumn 110, Issue 4, 2010, Pages 1198-1205

  Tomić, Maja A ^a   Vučković, Sonja M ^b   Stepanović Petrović, Radica M ^a   Ugrešić, Nenad D ^a   Prostran, Milica Š ^b   Bošković, Bogdan ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

MIRALGIN; OXCARBAZEPINE; PARACETAMOL; UNCLASSIFIED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG DOSE REDUCTION; DRUG POTENTIATION; HYPERALGESIA; MALE; MOUSE; NONHUMAN; PAW INFLAMMATORY HYPERALGESIA; PRIORITY JOURNAL; RAT; VISCERAL PAIN; WRITHING TEST;

EID: 77950967035     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181cbd8da     Document Type: Article

References (48)

1. Raffa RB. Pharmacology of oral combination analgesics: rational therapy for pain. J Clin Pharm Ther 2001;26:257-264
2. Botting R, Ayoub SS. COX-3 and the mechanism of action of paracetamol/acetaminophen. Prostaglandins Leukot Essent Fatty Acids 2005;72:85-87 (Pubitemid 40051224)
3. Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther 2005;12:46-55
4. Lee YS, Kim H, Brahim JS, Rowan J, Lee G, Dionne RA. Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation. Pain 2007;129:279-286 (Pubitemid 46754568)
5. Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 2007;22:383-390 (Pubitemid 351225574)
6. Miranda HF, Puig MM, Prieto JC, Pinardi G. Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain. Pain 2006;121:22-28 (Pubitemid 43261628)
7. Miranda HF, Sierralta F, Prieto JC. Synergism between NSAIDs in the orofacial formalin test in mice. Pharmacol Biochem Behav 2009;92:314-318
8. Qiu HX, Liu J, Kong H, Liu Y, Mei XG. Isobolographic analysis of the antinociceptive interactions between ketoprofen and paracetamol. Eur J Pharmacol 2007;557:141-146 (Pubitemid 46186289)
9. Miranda HF, Silva E, Pinardi G. Synergy between the antinociceptive effects of morphine and NSAIDs. Can J Physiol Pharmacol 2004;82:331-338 (Pubitemid 39093699)
10. Altman RD. A rationale for combining acetaminophen and NSAIDs for mild-to-moderate pain. Clin Exp Rheumatol 2004;22:110-117
11. Filitz J, Ihmsen H, Günther W, Tröster A, Schwilden H, Schüttler J, Koppert W. Supra-additive effects of tramadol and acetaminophen in a human pain model. Pain 2008;136:262-270 (Pubitemid 351680244)
12. Remy C, Marret E, Bonnet F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controlled trials. Br J Anaesth 2005;94:505-513 (Pubitemid 40500537)
13. Beydoun A, Kutluay E. Oxcarbazepine. Expert Opin Pharmacother 2002;3:59-71 (Pubitemid 34763963)
14. Fox A, Gentry C, Patel S, Kesingland A, Bevan S. Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig. Pain 2003;105:355-362 (Pubitemid 37162506)
15. Kiguchi S, Imamura T, Ichikawa K, Kojima M. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy. Clin Exp Pharmacol Physiol 2004; 31:57-64 (Pubitemid 38230749)
16. Jang Y, Kim ES, Park SS, Lee J, Moon DE. The suppressive effects of oxcarbazepine on mechanical and cold allodynia in a rat model of neuropathic pain. Anesth Analg 2005;101:800-806 (Pubitemid 41208514)
17. Tomić MA, Vucković SM, Stepanović-Petrović RM, Ugresić N, Prostran MS, Bosković B. The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists. Pain 2004;111:253-260 (Pubitemid 39201146)
18. Shannon HE, Eberle EL, Peters SC. Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats. Neuropharmacology 2005;48:1012-1020
19. Stepanović-Petrović RM, Tomić MA, Vučković SM, Paranos SLj, Ugrešić ND, Prostran MS, Milovanović S, Bošković B. Antinociceptive effects of anticonvulsants in a mouse visceral pain model. Anesth Analg 2008;106:1897-1903
20. Dogra S, Beydoun S, Mazzola J, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain 2005;9:543-554 (Pubitemid 41219786)
21. Beydoun A, Shaibani A, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand 2006;11:395-404 (Pubitemid 44046325)
22. Ichikawa K, Koyama N, Kiguchi S, Kojima M, Yokota T. Inhibitory effect of oxcarbazepine on high-frequency firing in peripheral nerve fibers. Eur J Pharmacol 2001;420:119-122 (Pubitemid 32537686)
23. Vučković SM, Tomić MA, Stepanović- Petrović RM, Ugrešić N, Prostran MS, Bošković B. The effects of alpha2-adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory pain. Pain 2006;125:10-19 (Pubitemid 44498960)
24. Stepanović-Petrović RM, Tomić MA, Vučković SM, Kocev N, Ugrešić ND, Prostran MS, Bošković B. GAB Aergic mechanisms are involved in the antihyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory hyperalgesia. Pharmacology 2008;82:53-58 (Pubitemid 351931410)
25. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn 1957; 111:409-419
26. Morris CJ. Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol 2003;225:115-121
27. Tallarida RJ, Murray RB. Manual of Pharmacologic Calculations with Computer Programs. 2nd ed. New York: Springer Verlag, 1986
28. Satyanarayana PS, Jain NK, Singh A, Kulkarni SK. Isobolographic analysis of interaction between cyclooxygenase inhibitors and tramadol in acetic acid-induced writhing in mice. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:641-649 (Pubitemid 38987389)
29. Tallarida RJ, Stone DJ Jr, Raffa RB. Efficient designs for studying synergistic drug combinations. Life Sci 1997;61: PL417-PL425
30. Tallarida RJ. The interaction index: a measure of drug synergism. Pain 2002;98:163-168
31. Yaksh TL, Noueihed RY, Durant PAC. Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in the rat and cat. Anesthesiology 1986;64:54-66
32. Tallarida RJ. Drug Synergism and Dose-Effect Data Analysis. 1st ed. Boca Raton, FL: Chapman & Hall/CRC, 2000
33. Rezende RM, França DS, Menezes GB, dos Reis WG, Bakhle YS, Francischi JN. Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain. Br J Pharmacol 2008;153:760-768
34. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992;263:136-146
35. Yoon MH, Yaksh TL. Evaluation of interaction between gabapentin and ibuprofen on the formalin test in rats. Anesthesiology 1999;91:1006-1013 (Pubitemid 29466536)
36. Yaksh TL, Dirig DM, Conway CM, Svensson C, Luo ZD, Isakson PC. The acute antihyperalgesic action of nonsteroidal, antiinflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001;21:5847-5853 (Pubitemid 32737717)
37. Bonnefont J, Chapuy E, Clottes E, Alloui A, Eschalier A. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 2005;114:482-490 (Pubitemid 40385886)
38. Tomić MA, Vučković SM, Stepanović- Petrović RM, Ugrešić N, Prostran MS, Bošković B. Peripheral anti-hyperalgesia by oxcarbazepine: involvement of adenosine A1 receptors. Pharmazie 2006;61:566-568 (Pubitemid 43989139)
39. Tomić MA, Vučković SM, Stepanović- Petrović RM, Ugrešić ND, Paranos SLj, Prostran MS, Bošković B. The involvement of peripheral alpha 2-adrenoceptors in the antihyperalgesic effect of oxcarbazepine in a rat model of inflammatory pain. Anesth Analg 2007;105:1474-1481 (Pubitemid 350303960)
40. Stepanović-Petrović R, Tomić M, Vuč ković S, Ugrešić N, Prostran M, Bošković B. Opioidergic mechanisms are not involved in the antihyperalgesic effects of carbamazepine and oxcarbazepine. Methods Find Exp Clin Pharmacol 2007;29:191-194 (Pubitemid 46918298)
41. Cottney J, Lewis AJ. Mechanisms of concanavalin A-induced inflammation in the rat. Br J Pharmacol 1975;53:445
42. Deraedt R, Jouquey S, Delevallée F, Flahaut M. Release of prostaglandins E and F in an algogenic reaction and its inhibition. Eur J Pharmacol 1980;61:17-24 (Pubitemid 10178021)
43. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev 2001;53:597-652 (Pubitemid 33136239)
44. Giamberardino MA. Recent and forgotten aspects of visceral pain. Eur J Pain 1999;3:77-92
45. Ayoub SS, Colville-Nash PR, Willoughby DA, Botting RM. The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice. Eur J Pharmacol 2006;538:57-65
46. Pechlivanova DM, Georgiev VP. Interaction of angiotensin II and adenosine A1 and A2A receptor ligands on the writhing test in mice. Pharmacol Biochem Behav 2002;72:23-28
47. Godoy MCM, Fighera MR, Souza FR, Flores AE, Rubin MA, Oliveira MR, Zanatta N, Martins MAP, Bonacorso HG, Mello CF. Alpha 2-adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazolones, but not of dipyrone. Eur J Pharmacol 2004;496:93-97 (Pubitemid 39024321)
48. Cervero F, Laird JMA. Visceral pain. Lancet 1999;353:2145-2148 (Pubitemid 29278493)